Welcome to our dedicated page for STANDEX INTERNATIONAL CORP/DE/ SEC filings (Ticker: SXI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on STANDEX INTERNATIONAL CORP/DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into STANDEX INTERNATIONAL CORP/DE/'s regulatory disclosures and financial reporting.
Standex International Corporation director reports stock purchase
A director of Standex International Corporation reported buying 1,500 shares of common stock on 08/29/2025 at a price of $205 per share. After this transaction, the director beneficially owns 6,000 shares of Standex common stock in direct ownership.
This report is an amendment that clarifies the transaction code, explaining that the original report inadvertently used a different code and that the transaction should be classified as a purchase.
Standex International Corporation (SXI) director transaction: A company director reported buying 2,000 shares of Standex common stock on 08/25/2025 at a price of $209.4959 per share. After this purchase, the director directly owns 4,500 shares of Standex common stock. This filing is an amended Form 4 that corrects the original report, which had mistakenly used transaction code "A"; the transaction is now shown as code "P", indicating an open market or private purchase.
Standex International (SXI) reported insider equity awards for its Chief HR Officer & VP on 11/10/2025. The filing shows an acquisition of 630 shares of common stock from a restricted stock grant, with 630 shares beneficially owned directly after the transaction.
The officer also received 378 Performance Share Units that cliff vest after a three‑year period, with the ultimate payout ranging from 0% to 250% of the award based on company performance metrics. In addition, 378 Restricted Stock Units were granted, scheduled to vest one‑third on August 23, 2026, one‑third on August 23, 2027, and one‑third on August 23, 2028.
Standex International (SXI) filed a Form 3 for a new insider. The reporting person is an officer, listed as Chief HR Officer & VP, with an event date of 11/10/2025. The filing states that no securities are beneficially owned by the officer at this time. This is an initial ownership report and reflects that the insider held no Standex stock or derivative securities when the reporting obligation began.
Standex International (SXI) announced leadership changes in human resources. The Board accepted the resignation of Chief Human Resources Officer and named executive officer Annemarie Bell, effective November 10, 2025. She will transition to a role focused on executive coaching and leadership development, supporting an organizational need while addressing a significant health challenge.
Effective the same date, the Board appointed Michelle Newbury as Chief Human Resources Officer. Newbury, age 46, will lead global HR strategy, including talent management, organizational development, compensation and benefits, diversity and inclusion, and employee engagement initiatives.
Standex International (SXI) reported an insider transaction by its Chief Strategy Officer. On November 5, 2025, the reporting person sold 650 shares of common stock at a weighted average price of $233.37.
After the transaction, the insider beneficially owns 5,047 shares, held directly. The filing notes the sale occurred in multiple trades within a price range of $232.91 to $233.865, and detailed trade breakdowns are available upon request.
SXI: A holder filed a Form 144 notice to sell up to 650 shares of common stock. The filing lists an aggregate market value of $151,714.10, an approximate sale date of 11/05/2025, and identifies Fidelity Brokerage Services LLC as broker, with sales on the NYSE.
The shares were acquired via restricted stock vesting from the issuer on 10/26/2024 as compensation. Shares outstanding were 12,116,999; this is a baseline figure, not the amount being offered.
Standex International (SXI) executive reported an insider sale. The Vice President/CFO/Treasurer sold 1,823 shares of common stock on 11/04/2025, coded S (sale) on Form 4. The transaction was reported at a weighted average price of $230.12, with individual trades executed between $229.66 and $230.23.
Following the sale, the reporting person directly beneficially owns 9,341 shares. The filing notes the seller will provide full pricing breakdowns upon request.
SXI filed a Form 144 indicating a proposed sale of up to 1,823 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of 11/04/2025 and an aggregate market value of $419,560.24.
The shares to be sold were acquired on 08/23/2025 via restricted stock vesting as compensation. Shares outstanding were 12,116,999.
Recent insider activity disclosed in the notice shows sales by Ademir Sarcevic over the past three months: 3,047 shares on 08/06/2025 for $584,446.61 and 1,085 shares on 08/26/2025 for $227,739.90. A Form 144 is a notice of potential sales by affiliates and does not obligate a sale to occur.
Standex International (SXI) reported an initial insider ownership filing. The company’s Chief Strategy Officer filed a Form 3 effective 10/27/2025, disclosing 5,697 shares of common stock, which includes 118 restricted shares subject to vesting.
The filing also lists derivative awards: phantom stock units tied to common stock of 161, 246, 352, 436, and 483 shares, and restricted stock units of 291 and 483 shares. Footnotes state phantom units vest after three years under the Management Stock Purchase Plan, performance share units cliff vest after a three‑year period subject to metrics, and RSUs vest one‑third annually.